Cargando…
1126. Learner Driven Call Center to increase Convalescent Plasma Donation in COVID-19
BACKGROUND: Convalescent plasma (CP) may be obtained from patients who have recovered from the novel coronavirus disease, COVID-19, caused by the virus SARS-CoV-2. Although not FDA approved, preliminary data suggests patients who receive convalescent plasma from recovered donors may have shortened r...
Autores principales: | Joyner, Nancy M, Deaney, Michael, Derrick, Caroline, Bouchard, Jeannette, Brown, Hannah G, Freeman, Kennedy J, Drummond, Malashia, Harper, Madeline, Waddell, Alexandria, Albrecht, Helmut, Weissman, Sharon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776494/ http://dx.doi.org/10.1093/ofid/ofaa439.1312 |
Ejemplares similares
-
1126. Three Cases of Neutropenic Enterocolitis Following Midostaurin Administration
por: Carroll, Ryan, et al.
Publicado: (2018) -
1126. Variability in Antibiotic Use in Children’s Hospitals in the United States
por: Griffith, Hannah, et al.
Publicado: (2019) -
Donating convalescent plasma for COVID-19 patients
por: Black, Emily
Publicado: (2020) -
1041. Tenofovir alafenamide associated weight change in persons living with HIV
por: Crowder, Carlysle E, et al.
Publicado: (2020) -
What is the optimal usage of coronavirus disease 2019 convalescent plasma donations?
por: Focosi, Daniele, et al.
Publicado: (2021)